George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 384,442 shares at $33.65 ($13.0M) on 2023-06-02, disclosed to the SEC on 2023-06-06.
Open-market sale of $13.0M RPRX by EVP, Investments & CLO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.54 | 1,686 | $57K | 0.4% |
| 2 | $33.54 | 1,686 | $57K | 0.4% |
| 3 | $33.65 | 92,221 | $3.1M | 23.9% |
| 4 | $33.65 | 92,221 | $3.1M | 23.9% |
| 5 | $33.54 | 19,215 | $644K | 5.0% |
| 6 | $33.54 | 19,215 |
| $644K |
| 5.0% |
| 7 | $33.82 | 79,099 | $2.7M | 20.6% |
| 8 | $33.82 | 79,099 | $2.7M | 20.6% |
| Total | $33.71 avg | 384,442 | $13.0M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |
| RPRX | SELL | 2023-02-27 | $1.9M | — | Filing → |